Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AVARP02017_P050 - Provider product page
- Provider
- Aviva Systems Biology
- Proper citation
- Aviva Systems Biology Cat#AVARP02017_P050, RRID:AB_841262
- Product name
- BRCA1 Antibody - N-terminal region (AVARP02017_P050)
- Antibody type
- Polyclonal
- Antigen
- The immunogen is a synthetic peptide directed towards the N terminal region of human BRCA1
- Description
- Affinity Purified
- Reactivity
- Human, Rat, Canine
- Host
- Rabbit
- Vial size
- 100 μl
- Concentration
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
- Storage
- For short term use, store at 2-8C up to 1 week. For long term storage, store at -20C in small aliquots to prevent freeze-thaw cycles.
Submitted references Lymphocyte infiltration, expression of interleukin (IL) -1, IL-6 and expression of mutated breast cancer susceptibility gene-1 correlate with malignancy of canine mammary tumours.
Kim JH, Yu CH, Yhee JY, Im KS, Sur JH
Journal of comparative pathology 2010 Feb-Apr;142(2-3):177-86
Journal of comparative pathology 2010 Feb-Apr;142(2-3):177-86
No comments: Submit comment
Supportive validation
- Submitted by
- Aviva Systems Biology (provider)
- Main image
- Experimental details
- WB SuggestedAntibody Titration: 0.2-1µg/ml. Positive Control: K562BRCA1 is supported by BioGPS gene expression data to be expressed in K562
Supportive validation
- Submitted by
- Aviva Systems Biology (provider)
- Main image
- Experimental details
- Human Muscle